Federal Register · Regulatory notice
Foreign-Trade Zone (FTZ) 39, Notification of Proposed Production Activity; Abbott Laboratories; (Diagnostic Medical Devices); Irving, Texas
A Notice notice explicitly mentions the company. Read the cited text for its role.
Follow ABT- Became public
- Aug 6, 2026
- Event / period date
- Not stated
- Collected
- Nov 8, 2026, 6:28 PM EST
Why this is connected
The source explicitly mentions ABBOTT LABORATORIES. A mention alone does not establish a financial benefit.
Source evidence
Read the source excerpt or record
Register Online via the Government Publishing Office [ www.gpo.gov ] [FR Doc No: 2026-15999] ----------------------------------------------------------------------- DEPARTMENT OF COMMERCE Foreign-Trade Zones Board [B-97-2026] Foreign-Trade Zone (FTZ) 39, Notification of Proposed Production Activity; Abbott Laboratories; (Diagnostic Medical Devices); Irving, Texas Abbott Laboratories submitted a notification of proposed production activity to the FTZ Board (the Board) for its facility in Irving, Texas within FTZ 39. The notification conforming to the requirements of the Board's regulations (15 CFR 400.22) was received on August 3, 2026. Pursuant to 15 CFR 400.14(b), FTZ production activity would be limited to the specific foreign-status material(s)/component(s) and specific finished product(s) described in the submitted notification (summarized below) and subsequently authorized by the Board. The benefits that may stem from conducting production activity under FTZ procedures are explained in the background section of the Board's website--accessible via www.trade.gov/ftz . The proposed finished products include: plastic fitting kits for waste pump quick connects; plastic fitting kits for buffer dilution systems; plastic waste containers; stainless steel screws and washers; indicator assemblies, including LEDs, optical sensors, plastic housing, wire harness and connectors; aluminu
Congressional trading in ABT
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Oct 30, 2026$1K–$15K
Rep. Thomas H. Kean, Jr. (R-NJ-7)
Sold (partial) Abbott Laboratories ABT
$1K–$15K · Traded Sep 17, 2026 · disclosed Oct 30, 2026
Committee overlap: Energy and Commerce - Oct 27, 2026$50K–$100K
Rep. Pete Sessions (R-TX-17)
$50K–$100K · Traded Oct 2, 2026 · disclosed Oct 27, 2026 · Spouse
- Oct 12, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Bought Abbott Laboratories ABT
$1K–$15K · Traded Sep 18, 2026 · disclosed Oct 12, 2026
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
Bought Abbott Laboratories ABT
$1K–$15K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- Aug 18, 2026$15K–$50K
Rep. Rick W. Allen (R-GA-12)
$15K–$50K · Traded Jul 14, 2026 · disclosed Aug 18, 2026 · Spouse
Committee overlap: Energy and CommerceTraded 2 days before earnings - Aug 14, 2026$1K–$15K
Rep. Richard McCormick (R-GA-7)
$1K–$15K · Traded Jul 30, 2026 · disclosed Aug 14, 2026
Got $2K from the company’s PAC - Aug 12, 2026$1K–$15K
Rep. Mike Kelly (R-PA-16)
$1K–$15K · Traded Jul 17, 2026 · disclosed Aug 12, 2026 · Spouse
- Jul 21, 2026$15K–$50K
Sen. Alan Armstrong (R-OK)
Sold (full) Abbott Laboratories ABT
$15K–$50K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.